Dabigatran etexilate Unknown Status Phase 2 Trials for Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs